Hosted on MSN

What is lecanemab, the newly approved Alzheimer's drug? Can it really slow down dementia?

Subscribe to our newsletter for the latest sci-tech news updates. Last week, Australia's Therapeutic Goods Administration (TGA) approved a new drug for early Alzheimer's diseases: lecanemab, sold ...

How a once-failed drug became a new hope for Alzheimer’s

An underdog Alzheimer's pill, ALZ-801, showed promise in a subgroup of mild cognitive impairment patients, slowing decline by ...
Yahoo

NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn

The NHS is “simply not ready” for a new era of diagnosing and treating Alzheimer’s disease and is not “keeping pace with the science”, experts have warned. New drugs and blood tests are set to ...
Medscape

More Evidence Lowering Amyloid Is Clinically Beneficial in Early Alzheimer’s

Reduced amyloid burden after treatment with the antiamyloid donanemab (Kisunla, Eli Lilly) correlated strongly with slower cognitive and functional decline in adults with early symptomatic Alzheimer’s ...

An Alzheimer's pill appears to protect some in a high-risk population

A new study is reviving hope that a twice-daily pill can slow down Alzheimer's in people whose genes put them at high risk ...
Medical Xpress

What is lecanemab, the newly approved Alzheimer's drug? Can it really slow down dementia?

There are many different causes of dementia, but Alzheimer's disease accounts for about 60%–80% of all cases. Last week, Australia's Therapeutic Goods Administration (TGA) approved a new drug for ...